ACKR2 and adenoma: The downregulation of ACKR2 expression in adenomas insignificantly increased along with cumulated risk for malignancy, expressed as a sum of high-risk factors such as the presence of villous component, high-grade of dysplasia, and adenoma size exceeding 10 mm [24].